|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.1 SEK | +6.49% |
|
+32.26% | +156.25% |
| 19/04 | Pila Pharma Appoints New CEO, Chief Scientific Officer | MT |
| 19/04 | Pila Pharma AB Announces Board and Management Appointments | CI |
Pila Pharma AB (publ) reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 0.366 million compared to SEK 0.413 million a year ago. Net loss was SEK 1.3 million compared to SEK 4.02 million a year ago.
Basic loss per share from continuing operations was SEK 0.06 compared to SEK 0.23 a year ago. Diluted loss per share from continuing operations was SEK 0.06 compared to SEK 0.23 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +156.25% | 9.26M | |
| +45.82% | 765B | |
| +40.95% | 632B | |
| -6.16% | 354B | |
| +19.86% | 331B | |
| +9.32% | 299B | |
| +18.45% | 248B | |
| -0.78% | 219B | |
| +11.88% | 216B | |
| +5.90% | 164B |
PILA PHARMA AB 
